M&G Leads $50M Funding For Bit.Bio In UK Drug Discovery
09 Jan 2026 //
PR NEWSWIRE
Südhof, bit.bio CEO Fireside on Programming Human Cells
29 Apr 2024 //
BUSINESSWIRE
Bit.bio Appoints Kathryn Corzo as Chief Operating Officer
17 Nov 2021 //
BUSINESSWIRE
Bit.bio raises $103m through series B round to develop cell therapies
08 Nov 2021 //
PHARMACEUTICAL-TECHNOLOGY

Market Place
Sourcing Support